Devenny D A, Silverman W P, Hill A L, Jenkins E, Sersen E A, Wisniewski K E
New York State University for Basic Research in Developmental Disabilities, USA.
J Intellect Disabil Res. 1996 Jun;40 ( Pt 3):208-21.
The ubiquitous presence of the neuropathology of Alzheimer disease (AD) in individuals with Down's syndrome (DS) over 40 years of age suggests that this group of people will exhibit a high prevalence of dementia of the Alzheimer type (DAT) as they age. The present study indicates that there is a clear discrepancy between the presumed presence of AD neuropathology and the clinical expression of DAT among older people with DS. In the first 6 years of a longitudinal study, the present authors compared 91 adults (31-63 years of age) with DS and mild or moderate mental retardation to 64 adults (31-76 years of age) with other forms of mental retardation (MR) on yearly measures of mental status, short- and long-term memory, speeded psychomotor function, and visuospatial organization. The results indicated that, over repeated testing on the verbal long-term memory test, younger participants with DS showed small increases in their scores, while older participants with DS showed very slight decreases. Overall performance scores on this test and a speeded psychomotor task were poorer for both diagnostic groups in individuals aged 50 years and older. The magnitude and type of these selective changes in performance were consistent with performance profiles observed in older healthy adults without mental retardation on tests measuring similar cognitive functions. Only four out of the 91 people with DS in the present sample showed changes in functioning that have led to a diagnosis of possible DAT, and in these individuals, alternative causes of performance declines were concurrently present (e.g. thyroid dysfunction). These findings indicate that some age-associated changes in functioning are related to "normal' but probably precocious ageing among adults with DS. Furthermore, these findings suggest that adults with DS and mild or moderate mental retardation may be at lower risk for dementia during their fourth and fifth decades of life than previous studies have suggested.
40岁以上的唐氏综合征(DS)患者中普遍存在阿尔茨海默病(AD)的神经病理学特征,这表明随着年龄增长,这群人患阿尔茨海默型痴呆(DAT)的患病率将会很高。目前的研究表明,在老年DS患者中,AD神经病理学的假定存在与DAT的临床表现之间存在明显差异。在一项纵向研究的前6年中,作者将91名患有DS且有轻度或中度智力障碍的成年人(31 - 63岁)与64名患有其他形式智力障碍(MR)的成年人(31 - 76岁)进行了比较,每年对他们的精神状态、短期和长期记忆、快速精神运动功能以及视觉空间组织进行测量。结果表明,在对言语长期记忆测试的多次重复测试中,年轻的DS参与者得分略有增加,而年长的DS参与者得分则略有下降。在50岁及以上的个体中,两个诊断组在该测试和快速精神运动任务上的总体表现得分均较差。这些表现上的选择性变化的幅度和类型与在没有智力障碍的健康老年人中进行的类似认知功能测试中观察到的表现特征一致。在本样本的91名DS患者中,只有4人表现出功能变化,导致可能被诊断为DAT,而在这些个体中,同时存在导致表现下降的其他原因(如甲状腺功能障碍)。这些发现表明,一些与年龄相关的功能变化与DS成年人中“正常”但可能早熟的衰老有关。此外,这些发现表明,患有DS且有轻度或中度智力障碍的成年人在其生命的第四和第五个十年患痴呆症的风险可能比以前的研究所表明的要低。